United Kingdom· GB-APID-45619311000001104
Acamprosate 333mg gastro-resistant tablets
A acamprosate product containing acamprosate, registered in United Kingdom by Somex Pharma. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Acamprosate is registered in 14 of 19 countries.
Countries holding a registration under ATC N07BB03 (acamprosate), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Acamprosate · ATC N07BB03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acamprosate costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $1.14 in France to $3.37 in Switzerland — a ×3.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acamprosate · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.37
- IT Italy$2.75
- FR France$1.14
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Acamprosate
- Manufacturer
- Somex Pharma
- Country
- United Kingdom (GB)
- ATC code
- N07BB03
- ATC class
- Acamprosate
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060089611820
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for acamprosate.
Graded by severity as the source publishes them — 19 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acamprosate · interactions on record
19 records
Same medicine, other countries
Acamprosate in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesacamprosate calciumZydus Pharmaceuticals (USA) Inc.
- SwedenAkamprosat Viatris 333 mg EnterotablettViatris Limited
- NetherlandsCampral 333 mg, maagsapresistente tablettenEuro Registratie Collectief B.V.
- IrelandCampral EC 333 mg Gastro-resistant tabletsIMED Healthcare Ltd.,
- FranceACAMPROSATE BIOGARAN 333 mg, comprimé pelliculé gastro-résistantBIOGARAN
- NorwayCampral2care4 ApS
- BelgiumCampral 333 mgMerck
- PolandCampralMerck Sante s.a.s.
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Campral
- Belgium · Campral
- Czechia · Campral
- Germany · Campral
- Spain · Campral
- France · Acamprosate Biogaran, Acamprosate Viatris
- Ireland · Campral Ec
- Italy · Campral
- Luxembourg · Campral
- Netherlands · Campral
- Norway · Campral
- Poland · Campral
- Portugal · Campral
- Sweden · Akamprosat Viatris, Campral
- Slovakia · Acamprosat Viatris, Campral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0636ca4-231b-4a27-9026-2455c5a01220 GET /v1/drugs/b0636ca4-231b-4a27-9026-2455c5a01220?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45619311000001104",
"desc": "Acamprosate 333mg gastro-resistant tablets (Somex Pharma)",
"form": "Gastro-resistant tablet",
"vpid": "42267511000001104",
"source": "dmd",
"vtm_id": "774403002",
"strength": "333 mg",
"substance": "Acamprosate",
"ingredient": "Acamprosate calcium",
"supplier_code": "9765711000001104"
}See everything about acamprosate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.